Drug profile · INN
zanubrutinib
BRUKINSA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
zanubrutinib (BRUKINSA) is an FDA-listed pharmaceutical active ingredient. Associated with Beone Medicines Ireland Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN zanubrutinib
Brand BRUKINSA
Route ORAL
Formulation CAPSULE
ATC code L01EL03
Originator Beone Medicines Ireland Limited
Frequently asked questions
What is zanubrutinib?
zanubrutinib (BRUKINSA) is an FDA-listed pharmaceutical active ingredient. Associated with Beone Medicines Ireland Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for zanubrutinib?
BRUKINSA is a marketed brand name for zanubrutinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of zanubrutinib?
zanubrutinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.